Investigating severe infections in pediatric intensive care units in China

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a high-quality standardized clinical database for pediatric intensive care unit (PICU) inpatients across major cities in China. It will collect data on the incidence, fatality rates, pathogen distribution, and anti-infective treatments for community-acquired and nosocomial infections among patients admitted to the PICU from January 1, 2016, to December 31, 2025. All patients will be followed until death or withdrawal from the PICU, allowing for comprehensive analysis of clinical outcomes and treatment efficacy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PICU patients with severe infection

Exclusion Criteria:

* Non-infected patient

Where it's running

• Children's Hospital of Fudan University
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Principal investigator: Guoping Lu, Doctor — Children's Hospital of Fudan University
• Study coordinator: Guoping Lu, Doctor
• Email: 13788904150@163.com
• Phone: 13788904150

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Infectious complications in blood cancer patients treated with bispecific antibodies

  This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.

  Recruiting at 2 sites Infanta Leonor University Hospital · Madrid, Madrid and 1 other locations · NCT07609576

• N-acetylcysteine for severe infection with liver dysfunction in adults

  In adults with acute infection or sepsis and liver dysfunction, this study tests whether giving N-acetylcysteine in a four-hour infusion improves days alive and out of the hospital in the first 14 days.

  Recruiting Phase 4 University Hospital Bispebjerg and Frederiksberg · Copenhagen · NCT07273071

• Continuous infusion vs intermittent dosing of ceftazidime/avibactam in critically ill patients

  This study tests whether giving ceftazidime/avibactam as a continuous infusion works better than standard intermittent dosing for seriously ill ICU patients with certain resistant infections.

  Recruiting Phase 4 Clinical Hospital Centre Zagreb · Zagreb · NCT06811727

• Monitoring severe bacterial infections in hospitalized children

  This study looks at how common and serious bacterial infections are in children in intensive care to help improve how these infections are treated and prevented.

  Recruiting Association Clinique Thérapeutique Infantile du val de Marne · Créteil · NCT06260345

• Descriptive study of severe infections treated with phage therapy

  This study looks at how well phage therapy works for people with severe infections by gathering information from 250 patients treated at a hospital in Lyon.

  Recruiting Hospices Civils de Lyon · Lyon · NCT06185920

• Individualized vancomycin dosing for severe infections

  This study tests if giving personalized doses of vancomycin can help people with severe infections do better than the standard dosing method.

  Recruiting Phase 4 Central South University · Changsha, Hunan · NCT06161870

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.